---
title: "Enliven Therapeutics falls 5% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304514514.md"
description: "Enliven Therapeutics fell 5.44% to US$44.68. Up 7.46% over six months and up 190.13% YTD."
datetime: "2026-11-05T19:05:27.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304514514.md)
  - [en](https://longbridge.com/en/news/304514514.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304514514.md)
generator: "portal-rs"
---

# Enliven Therapeutics falls 5% during regular trading

Enliven Therapeutics (ELVN.US) fell more than **5%** during regular trading to **$44.68**.

The stock is up 6.56% over the past ten sessions, up 7.46% over the past six months and up 190.13% year to date. It sits 28.31% below its 52-week high of US$62.32.

The Nasdaq Composite is down 6.94% over the past five sessions and up 4.84% year to date.

The pharmaceuticals industry index fell 1.8% over the same period.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [ELVN.US](https://longbridge.com/en/quote/ELVN.US.md)

## Related News & Research

- [Enliven Therapeutics Chief Medical Officer Helen Louise Collins reports sale of $234,203.1101 in common shares](https://longbridge.com/en/news/306180389.md)
- [ELVN: Second-line-plus phase III launch is imminent, with a potential early-2029 readout](https://longbridge.com/en/news/305860981.md)
- [Jabil (JBL) Heads Into Earnings As Its AI Narrative Keeps Undervalued View Alive](https://longbridge.com/en/news/306391907.md)
- [Wall St Week Ahead-'Black Friday' brings consumer spending into focus for AI-rocked market](https://longbridge.com/en/news/306395310.md)
- [Space Exploration Technologies (SPCX) Gets A New Hiring Twist As Musk Eyes Top AI Talent](https://longbridge.com/en/news/306383945.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**